X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE IPCA LABS TTK HEALTHCARE/
IPCA LABS
 
P/E (TTM) x 19.1 29.7 64.3% View Chart
P/BV x 4.9 4.4 111.7% View Chart
Dividend Yield % 0.6 0.1 554.4%  

Financials

 TTK HEALTHCARE   IPCA LABS
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
IPCA LABS
Mar-18
TTK HEALTHCARE/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs663695 95.4%   
Low Rs399400 99.8%   
Sales per share (Unadj.) Rs535.6260.2 205.9%  
Earnings per share (Unadj.) Rs15.919.0 84.1%  
Cash flow per share (Unadj.) Rs20.033.1 60.6%  
Dividends per share (Unadj.) Rs4.001.00 400.0%  
Dividend yield (eoy) %0.80.2 412.4%  
Book value per share (Unadj.) Rs137.6213.0 64.6%  
Shares outstanding (eoy) m7.77126.20 6.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.02.1 47.1%   
Avg P/E ratio x33.328.9 115.4%  
P/CF ratio (eoy) x26.516.6 160.1%  
Price / Book Value ratio x3.92.6 150.1%  
Dividend payout %25.15.3 475.9%   
Avg Mkt Cap Rs m4,12769,120 6.0%   
No. of employees `0001.713.3 12.9%   
Total wages/salary Rs m6077,359 8.2%   
Avg. sales/employee Rs Th2,436.72,477.4 98.4%   
Avg. wages/employee Rs Th355.2555.2 64.0%   
Avg. net profit/employee Rs Th72.5180.6 40.2%   
INCOME DATA
Net Sales Rs m4,16232,836 12.7%  
Other income Rs m61418 14.6%   
Total revenues Rs m4,22333,254 12.7%   
Gross profit Rs m1974,505 4.4%  
Depreciation Rs m321,777 1.8%   
Interest Rs m30240 12.4%   
Profit before tax Rs m1972,905 6.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73511 14.2%   
Profit after tax Rs m1242,394 5.2%  
Gross profit margin %4.713.7 34.5%  
Effective tax rate %37.017.6 210.4%   
Net profit margin %3.07.3 40.8%  
BALANCE SHEET DATA
Current assets Rs m1,62919,455 8.4%   
Current liabilities Rs m1,05810,076 10.5%   
Net working cap to sales %13.728.6 48.0%  
Current ratio x1.51.9 79.7%  
Inventory Days Days3098 30.4%  
Debtors Days Days3467 50.2%  
Net fixed assets Rs m55620,260 2.7%   
Share capital Rs m78252 30.8%   
"Free" reserves Rs m87826,633 3.3%   
Net worth Rs m1,06926,886 4.0%   
Long term debt Rs m1592,340 6.8%   
Total assets Rs m2,39941,173 5.8%  
Interest coverage x7.613.1 57.9%   
Debt to equity ratio x0.10.1 170.5%  
Sales to assets ratio x1.70.8 217.5%   
Return on assets %6.46.4 100.2%  
Return on equity %11.68.9 130.1%  
Return on capital %18.510.8 171.5%  
Exports to sales %0.847.6 1.7%   
Imports to sales %1.414.9 9.4%   
Exports (fob) Rs m3315,642 0.2%   
Imports (cif) Rs m584,884 1.2%   
Fx inflow Rs m3315,642 0.2%   
Fx outflow Rs m634,884 1.3%   
Net fx Rs m-3010,759 -0.3%   
CASH FLOW
From Operations Rs m1273,411 3.7%  
From Investments Rs m-146-1,354 10.8%  
From Financial Activity Rs m22-1,304 -1.7%  
Net Cashflow Rs m3753 0.3%  

Share Holding

Indian Promoters % 65.4 45.9 142.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 11.4 32.5%  
FIIs % 5.2 25.3 20.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.4 148.3%  
Shareholders   12,723 36,892 34.5%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   DR. DATSONS LABS  STRIDES PHARMA SCIENCE  J.B.CHEMICALS  JUBILANT LIFE SCIENCES  BIOCON   

Compare TTK HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Marginally Higher, Oil Prices, and Top Cues in Focus Today(Pre-Open)

Indian share markets witnessed volatility during closing hours yesterday and ended their day marginally higher.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY19); Net Profit Up 51.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, IPCA LABS has posted a net profit of Rs 2 bn (up 51.7% YoY). Sales on the other hand came in at Rs 9 bn (up 10.3% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY19); Net Profit Up 24.1% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, IPCA LABS has posted a net profit of Rs 1 bn (up 24.1% YoY). Sales on the other hand came in at Rs 10 bn (up 15.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY19); Net Profit Down 423.6% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, IPCA LABS has posted a net profit of Rs 655 m (down 423.6% YoY). Sales on the other hand came in at Rs 9 bn (up 19.8% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

Sensex Nearing All-Time Highs: Stocks to Buy in this Rally(Profit Hunter)

Mar 14, 2019

The BSE Sensex is heating up. In just a few days, the benchmark index is up 3%. Is this rally sustainable? Richa finds out...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Mar 20, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS